FindTrial
Sign In

A phase III, multicentre, single blind, randomised controlled trial in the use of hyperbaric oxygen therapy versus biofeedback therapy in patients with chronic faecal incontinence associated with pudendal neuropathy

A phase III, multicentre, single blind, randomised controlled trial in the use of hyperbaric oxygen therapy versus biofeedback therapy in patients with chronic faecal incontinence associated with pudendal neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN85575959
Enrollment
100
Registered
2003-09-12
Start date
2003-01-22
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Faecal incontinence Signs and Symptoms

Interventions

A) hyperbaric oxygen therapy versus B) biofeedback.

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 100 patients, 50 on each arm.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026